Michele Ferenci

Michele Ferenci, PhD serves as Associate Professor and Chief of Medical Physics within the Department of Radiation Oncology at Penn State Cancer Institute, part of Penn State University. Holding Diplomate status with the American Board of Radiology (DABR), Ferenci leads medical physics operations in a clinical radiation oncology setting, focusing on advanced radiotherapy techniques and quality assurance protocols.

Ferenci's research spans radiation therapy physics with particular expertise in intensity-modulated radiation therapy (IMRT), brachytherapy applications, neutron dosimetry, and quality assurance methodologies. Key research areas include MRI-guided radiotherapy optimization, High Dose-Rate (HDR) brachytherapy procedures, and specialized radiation delivery systems for complex anatomical sites. The research fingerprint shows strong concentration in radiation therapy (85%), intensity-modulated radiation therapy (75%), and neutron dosimetry (75%).

Recent publications reveal consistent scholarly output since 2003, with notable 2024 work on MRI-guided radiotherapy for thoracic tumors examining clinical factors affecting treatment efficiency. The publication record demonstrates specialization in technical radiotherapy aspects including IMRT QA, brachytherapy applicator digitization, and specialized radiation delivery systems. Research trends show progression from fundamental dosimetry work toward increasingly complex image-guided and specialized radiotherapy applications.

• Diplomate, American Board of Radiology (DABR)

As Chief of Medical Physics, Ferenci oversees clinical physics operations including treatment planning, quality assurance, and radiation safety protocols. The position involves direct responsibility for medical physics staff and integration of advanced radiotherapy technologies into clinical practice. Research activities indicate collaboration with radiation oncologists, neurosurgeons, and medical physicists across multiple institutions, particularly evident in the Gamma Knife radiosurgery preclinical study and multi-institutional brachytherapy research.